Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study
Journal of Viral Hepatitis, 05/17/2012Tangkijvanich P et al.
Treatment with PEG–IFN plus RBV for 24 weeks may be sufficient for patients with genotype 6 who achieve RVR. Prospective randomized trials are required to evaluate this response–guided strategy in a larger number of patients with genotype 6.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.